HLA Analysis in Autoimmune Encephalitis and Related Disorders: Part II
Condition(s):Autoimmune Encephalitis; Paraneoplastic Neurological SyndromeLast Updated:April 1, 2021Recruiting
Include Studies Not Open or Pending
Condition(s):Autoimmune Encephalitis; Paraneoplastic Neurological SyndromeLast Updated:April 1, 2021Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:January 2, 2024Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:September 13, 2023Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:February 7, 2022Recruiting
Condition(s):Paraneoplastic Neurological Syndromes or Autoimmune EncephalitisLast Updated:February 29, 2024Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:December 1, 2022Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:February 3, 2023Not yet recruiting
Condition(s):Autoimmune Encephalitis; Paraneoplastic Neurological SyndromeLast Updated:March 16, 2023Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:January 26, 2024Recruiting
Condition(s):Autoimmune EncephalitisLast Updated:November 22, 2023Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.